bioRxivImmunology
HIV skews the SARS-CoV-2 B cell response toward an extrafollicular maturation pathway
R. Krause, COMMIT-KZN Team, J. Snyman, S.-H. Hwa, D. Muema, F. Karim, Y. Ganga, A. Ngoepe, Y. Zungu, I. Gazy, M. Bernstein, K. Khan, M. Mazibuko, N. Mthabela, D. Ramjit, O. Limbo, J. Jardine, D. Sok, I. A. Wilson, W. Hanekom, A. Sigal, H. Kloverpris, T. Ndung'u, A. Leslie
Abstract
BackgroundHIV infection dysregulates the B cell compartment, affecting memory B cell formation and the antibody response to infection and vaccination. Understanding the B cell response to SARS-CoV-2 in people living with HIV (PLWH) may explain the increased morbidity, reduced vaccine efficacy, reduced clearance, and intra-host evolution of SARS-CoV-2 observed in some HIV-1 coinfections. MethodsWe compared B cell responses to COVID-19 in PLWH and HIV negative (HIV-ve) patients in a cohort recruited in Durban, South Africa, during the first pandemic wave in July 2020 using detailed flow cytometry phenotyping of longitudinal samples with markers of B cell maturation, homing and regulatory features. ResultsThis revealed a coordinated B cell response to COVID-19 that differed significantly between HIV-ve and PLWH. Memory B cells in PLWH displayed evidence of reduced germinal center (GC) activity, homing capacity and class-switching responses, with increased PD-L1 expression, and decreased Tfh frequency. This was mirrored by increased extrafollicular (EF) activity, with dynamic changes in activated double negative (DN2) and activated naive B cells, which correlated with anti-RBD-titres in these individuals. An elevated SARS-CoV-2 specific EF response in PLWH was confirmed using viral spike and RBD bait proteins. ConclusionsDespite similar disease severity, these trends were highest in participants with uncontrolled HIV, implicating HIV in driving these changes. EF B cell responses are rapid but give rise to lower affinity antibodies, less durable long-term memory, and reduced capacity to adapt to new variants. Further work is needed to determine the long-term effects of HIV on SARS-CoV-2 immunity, particularly as new variants emerge. FundingThis work was supported by a grant from the Wellcome Trust to the Africa Health Research Institute (Wellcome Trust Strategic Core Award [grant number 201433/Z/16/Z]). Additional funding was received from the South African Department of Science and Innovation through the National Research Foundation (South African Research Chairs Initiative, [grant number 64809]), and the Victor Daitz Foundation.
- organism: human
- assay: flow cytometry
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Attenuated humoral responses in HIV infection after SARS-CoV-2 vaccination are linked to global B cell defects and cellular immune profiles
E. Touizer, A. Alrubbayi, … L. E. McCoy·bioRxiv·Nov 11, 2022
- Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
A. Alrubayyi, E. Gea-Mallorqui, … D. Peppa·bioRxiv·Feb 15, 2021
- Immunogenicity of COVID-19 vaccines and their effect on the HIV reservoir in older people with HIV
V. A. Matveev, E. Z. Mihelic, … M. Ostrowski·bioRxiv·Jun 14, 2023
- Changes in the senescence profile and immune checkpoints in HIV-infected individuals after COVID-19
C. Crespo-Bermejo, O. Brochado-Kith, … V. Briz·bioRxiv·Mar 12, 2024
- Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
A. Sokal, P. Chappert, … M. Mahevas·bioRxiv·Nov 17, 2020
- Evolution of Antibody Immunity to SARS-CoV-2
C. Gaebler, Z. Wang, … R. Patel·bioRxiv·Nov 3, 2020